Evidence map›Paper›PMID 42675739›Full record

ArticleMedicine2026

Causal relationship between immune factors and Guillain-Barré syndrome: A Mendelian randomization study.

Taichuan Xu, Xingguo Zhang, Xianfa Xu, Wentao Xiao, Wenjie Li, Xian Zhang

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Taichuan XuDepartment of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xingguo ZhangDepartment of Spine, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China.
Xianfa XuDepartment of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Wentao XiaoDepartment of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Wenjie LiDepartment of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xian ZhangDepartment of Spine, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China.ORCID 0009-0005-1579-1516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guillain-Barré syndrome (GBS) is an immune-mediated polyneurogenic disorder that is strongly correlated with immune factors. However, causal relationships between these factors remain unclear. We used 2-sample Mendelian randomization (MR) and inverse MR analysis. Immune factors were used as the outcome for GBS exposure. Cochrane Q test was used to detect heterogeneity. Simultaneously, the MR-Egger intercept test and MR-Pleiotropy Residual Sum and Outlier tests were used to check for horizontal pleiotropy. MR Steiger was used to estimate the direction of causal inference when the instrumental variables were insufficient in inverse MR. Eighteen immune traits and 1 inflammatory protein were identified as causally involved in the risk of GBS. Reverse MR revealed that GBS was correlated with the levels of eleven immune traits. The sensitivity analyses did not identify any potential heterogeneity or horizontal pleiotropy. Steiger did not find any evidence of reverse causation. We used 2-sample MR to investigate the causal relationship between immune factors and GBS, and our results provide clues for further research.

Indexed as

Guillain-Barre SyndromeImmunologic FactorsMendelian Randomization AnalysisHumansImmunologic Factorscausal inferenceGuillain-Barré syndromeimmune traitsinflammatory proteinsMendelian randomization

Identifiers

PMID42675739
PMCPMC13529122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.